Importance: Effects of thrombolysis in acute ischemic stroke are time-dependent. Ambulances that can administer thrombolysis (mobile stroke units [MSUs]) before arriving at the hospital have been shown to reduce time to treatment. Objective: To determine whether dispatch of MSUs is associated with better clinical outcomes for patients with acute ischemic stroke. Design, Setting, and Participants: This prospective, nonrandomized, controlled intervention study was conducted in Berlin, Germany, from February 1, 2017, to October 30, 2019. If an emergency call prompted suspicion of stroke, both a conventional ambulance and an MSU, when available, were dispatched. Functional outcomes of patients with final diagnosis of acute cerebral ischemia who were eligible for thrombolysis or thrombectomy were compared based on the initial dispatch (both MSU and conventional ambulance or conventional ambulance only). Exposure: Simultaneous dispatch of an MSU (computed tomographic scanning with or without angiography, point-of-care laboratory testing, and thrombolysis capabilities on board) and a conventional ambulance (n = 749) vs conventional ambulance alone (n = 794). Main Outcomes and Measures: The primary outcome was the distribution of modified Rankin Scale (mRS) scores (a disability score ranging from 0, no neurological deficits, to 6, death) at 3 months. The coprimary outcome was a 3-tier disability scale at 3 months (none to moderate disability; severe disability; death) with tier assignment based on mRS scores if available or place of residence if mRS scores were not available. Common odds ratios (ORs) were used to quantify the association between exposure and outcome; values less than 1.00 indicated a favorable shift in the mRS distribution and lower odds of higher levels of disability. Results: Of the 1543 patients (mean age, 74 years; 723 women [47%]) included in the adjusted primary analysis, 1337 (87%) had available mRS scores (primary outcome) and 1506 patients (98%) had available the 3-tier disability scale assessment (coprimary outcome). Patients with an MSU dispatched had lower median mRS scores at month 3 (1; interquartile range [IQR], 0-3) than did patients without an MSU dispatched (2; IQR, 0-3; common OR for worse mRS, 0.71; 95% CI, 0.58-0.86; P < .001). Similarly, patients with an MSU dispatched had lower 3-month coprimary disability scores: 586 patients (80.3%) had none to moderate disability; 92 (12.6%) had severe disability; and 52 (7.1%) had died vs patients without an MSU dispatched: 605 (78.0%) had none to moderate disability; 103 (13.3%) had severe disability; and 68 (8.8%) had died (common OR for worse functional outcome, 0.73, 95% CI, 0.54-0.99; P = .04). Conclusions and Relevance: In this prospective, nonrandomized, controlled intervention study of patients with acute ischemic stroke in Berlin, Germany, the dispatch of mobile stroke units, compared with conventional ambulances alone, was significantly associated with lower global disability at 3 months. Clinical trials in other regions are warranted.
Importance: Effects of thrombolysis in acute ischemic stroke are time-dependent. Ambulances that can administer thrombolysis (mobile stroke units [MSUs]) before arriving at the hospital have been shown to reduce time to treatment. Objective: To determine whether dispatch of MSUs is associated with better clinical outcomes for patients with acute ischemic stroke. Design, Setting, and Participants: This prospective, nonrandomized, controlled intervention study was conducted in Berlin, Germany, from February 1, 2017, to October 30, 2019. If an emergency call prompted suspicion of stroke, both a conventional ambulance and an MSU, when available, were dispatched. Functional outcomes of patients with final diagnosis of acute cerebral ischemia who were eligible for thrombolysis or thrombectomy were compared based on the initial dispatch (both MSU and conventional ambulance or conventional ambulance only). Exposure: Simultaneous dispatch of an MSU (computed tomographic scanning with or without angiography, point-of-care laboratory testing, and thrombolysis capabilities on board) and a conventional ambulance (n = 749) vs conventional ambulance alone (n = 794). Main Outcomes and Measures: The primary outcome was the distribution of modified Rankin Scale (mRS) scores (a disability score ranging from 0, no neurological deficits, to 6, death) at 3 months. The coprimary outcome was a 3-tier disability scale at 3 months (none to moderate disability; severe disability; death) with tier assignment based on mRS scores if available or place of residence if mRS scores were not available. Common odds ratios (ORs) were used to quantify the association between exposure and outcome; values less than 1.00 indicated a favorable shift in the mRS distribution and lower odds of higher levels of disability. Results: Of the 1543 patients (mean age, 74 years; 723 women [47%]) included in the adjusted primary analysis, 1337 (87%) had available mRS scores (primary outcome) and 1506 patients (98%) had available the 3-tier disability scale assessment (coprimary outcome). Patients with an MSU dispatched had lower median mRS scores at month 3 (1; interquartile range [IQR], 0-3) than did patients without an MSU dispatched (2; IQR, 0-3; common OR for worse mRS, 0.71; 95% CI, 0.58-0.86; P < .001). Similarly, patients with an MSU dispatched had lower 3-month coprimary disability scores: 586 patients (80.3%) had none to moderate disability; 92 (12.6%) had severe disability; and 52 (7.1%) had died vs patients without an MSU dispatched: 605 (78.0%) had none to moderate disability; 103 (13.3%) had severe disability; and 68 (8.8%) had died (common OR for worse functional outcome, 0.73, 95% CI, 0.54-0.99; P = .04). Conclusions and Relevance: In this prospective, nonrandomized, controlled intervention study of patients with acute ischemic stroke in Berlin, Germany, the dispatch of mobile stroke units, compared with conventional ambulances alone, was significantly associated with lower global disability at 3 months. Clinical trials in other regions are warranted.
Authors: Alexander Kunz; Christian H Nolte; Hebun Erdur; Jochen B Fiebach; Frederik Geisler; Michal Rozanski; Jan F Scheitz; Kersten Villringer; Carolin Waldschmidt; Joachim E Weber; Matthias Wendt; Benjamin Winter; Katja Zieschang; Ulrike Grittner; Sabina Kaczmarek; Matthias Endres; Martin Ebinger; Heinrich J Audebert Journal: Circulation Date: 2017-05-02 Impact factor: 29.690
Authors: Heinrich Audebert; Klaus Fassbender; M Shazam Hussain; Martin Ebinger; Guillaume Turc; Ken Uchino; Stephen Davis; Anne Alexandrov; James Grotta Journal: Int J Stroke Date: 2017-09-05 Impact factor: 5.266
Authors: Joon-Tae Kim; Gregg C Fonarow; Eric E Smith; Mathew J Reeves; Digvijaya D Navalkele; James C Grotta; Maria V Grau-Sepulveda; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm; Jeffrey L Saver Journal: Circulation Date: 2016-11-04 Impact factor: 29.690
Authors: Klaus Fassbender; James C Grotta; Silke Walter; Iris Q Grunwald; Andreas Ragoschke-Schumm; Jeffrey L Saver Journal: Lancet Neurol Date: 2017-02-15 Impact factor: 44.182
Authors: Martin Ebinger; Peter Harmel; Christian H Nolte; Ulrike Grittner; Bob Siegerink; Heinrich J Audebert Journal: Int J Stroke Date: 2017-03-22 Impact factor: 5.266
Authors: A Kobayashi; A Czlonkowska; G A Ford; A C Fonseca; G J Luijckx; J Korv; N Pérez de la Ossa; C Price; D Russell; A Tsiskaridze; M Messmer-Wullen; J De Keyser Journal: Eur J Neurol Date: 2018-01-12 Impact factor: 6.089
Authors: Christian H Nolte; Martin Ebinger; Jan F Scheitz; Alexander Kunz; Hebun Erdur; Frederik Geisler; Tim Bastian Braemswig; Michal Rozanski; Joachim E Weber; Matthias Wendt; Katja Zieschang; Jochen B Fiebach; Kersten Villringer; Ulrike Grittner; Sabina Kaczmarek; Matthias Endres; Heinrich J Audebert Journal: Stroke Date: 2018-02-19 Impact factor: 7.914
Authors: Jeffrey L Saver; Gregg C Fonarow; Eric E Smith; Mathew J Reeves; Maria V Grau-Sepulveda; Wenqin Pan; Daiwai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm Journal: JAMA Date: 2013-06-19 Impact factor: 56.272
Authors: Praveen Hariharan; Muhammad Bilal Tariq; James C Grotta; Alexandra L Czap Journal: Curr Neurol Neurosci Rep Date: 2022-02-07 Impact factor: 5.081
Authors: Nathaniel R Ellens; Derrek Schartz; Redi Rahmani; Sajal Medha K Akkipeddi; Adam G Kelly; Curtis G Benesch; Stephanie A Parker; Jason L Burgett; Diana Proper; Webster H Pilcher; Thomas K Mattingly; James C Grotta; Tarun Bhalla; Matthew T Bender Journal: Front Neurol Date: 2022-05-09 Impact factor: 4.086
Authors: Clemens Möllenhoff; Patrick Andreas Eder; Asarnusch Rashid; Christian Möllenhoff; Ingolf Römer; Bogdan Franczyk Journal: Anaesthesiologie Date: 2022-01-06
Authors: Gordian J Hubert; Nikolai D Hubert; Christian Maegerlein; Frank Kraus; Hanni Wiestler; Peter Müller-Barna; Wolfgang Gerdsmeier-Petz; Christoph Degenhart; Katharina Hohenbichler; Dennis Dietrich; Thomas Witton-Davies; Angelika Regler; Laura Paternoster; Miriam Leitner; Florian Zeman; Michael Koller; Ralf A Linker; Philip M Bath; Heinrich J Audebert; Roman L Haberl Journal: JAMA Date: 2022-05-10 Impact factor: 157.335
Authors: Matthew T Bender; Thomas K Mattingly; Redi Rahmani; Diana Proper; Walter A Burnett; Jason L Burgett; Joshua LEsperance; Jeremy T Cushman; Webster H Pilcher; Curtis G Benesch; Adam G Kelly; Tarun Bhalla Journal: Stroke Vasc Neurol Date: 2021-12-24